LUNG FY 2019 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$72M

FY 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$33M+62.9% YoY

Gross Profit

$22M68.8% margin

Operating Income

-$18M-54.7% margin

Net Income

-$21M-63.5% margin

EPS (Diluted)

$-0.58

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$364,000

Balance Sheet

Total Assets

$54M

Total Liabilities

$241M

Stockholders' Equity

-$187M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$20M	+62.9%
Gross Profit	$22M	$12M	+82.4%
Operating Income	-$18M	-$15M	-18.5%
Net Income	-$21M	-$18M	-12.0%